ArticleJournal of neuropsychology2026
An open label investigation of the feasibility and effectiveness of Memory Boost: A novel brief group cognitive remediation intervention for adults with mixed mood and anxiety disorders.
Article in Journal of neuropsychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To evaluate the feasibility and effectiveness of a novel group cognitive remediation (Memory Boost) designed to improve memory in an adult mixed mood and anxiety disorder population. A secondary aim was to explore the relationship between mood symptoms and performance on subjective and objective memory measures. Participants were adults (n = 99) being treated for a primary diagnosis of a mood disorder in an ambulatory mental health and addictions program who completed Memory Boost between 2014 and 2020. Assessments were completed pre- and post-intervention using self-report measures of mood, anxiety and stress, subjective memory difficulties, confidence in memory and use of memory strategies. Selected subtests of the Rivermead Behavioural Memory Test were administered as objective measures of memory. Over 76% of the sample was retained to post-group test completion. There were significant improvements on subjective measures of memory satisfaction, capability, use of strategies and frequency of mistakes; no significant changes in objective memory performance were observed. Significant improvements were noted in self-reported ratings of depression symptoms, with a significant positive correlation noted between changes in subjective memory and mood improvement. Results indicate that participation in Memory Boost was feasible and associated with improved subjective perception of memory and increased use of cognitive compensatory strategies in a mixed diagnosis adult mood and anxiety disorder sample. Improvement in self-reported mood was also noted and positively correlated with changes in subjective memory, suggesting that a brief cognitive remediation intervention may be a feasible and effective adjunct therapy to mood disorders treatment as usual.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.